Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF NOVEMBER 05, 2022 SAM #7645
SPECIAL NOTICE

B -- The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System.

Notice Date

11/3/2022 5:39:29 AM
 

Notice Type

Special Notice
 

NAICS

54171 — Research and Development in the Physical, Engineering, and Life SciencesT
 

Contracting Office

FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
 

ZIP Code

20993
 

Solicitation Number

FDARFI10282022
 

Response Due

12/12/2022 11:00:00 AM
 

Point of Contact

Howard S. Yablon
 

E-Mail Address

howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
 

Description

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System. FDA seeks information that will assist in the exploration of alternative approaches to meet FDA�s legal requirements and fulfill its public health mission by adding value to the Sentinel System. �Specifically, FDA is interested in organizational capabilities that will support the development of an efficient and economical product safety surveillance system that is not limited to the use of a common data model and a distributed data partners network and instead leverages multiple technical approaches. See Attachments for RFI.and Appendix A.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/4ca6bfd7de07401d8d818d0bf337f472/view)
 

Place of Performance

Address: Silver Spring, MD 20903, USA

Zip Code: 20903

Country: USA
 

Record

SN06508960-F 20221105/221103230056 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |